Pancreatic Cancer

>

Latest News

The incorporation of palliative care specific to mental health services and therapy remains underutilized in the care of patients with pancreatic cancer.
Palliative Care May Improve Mental Health in Pancreatic Cancer Diagnoses

November 19th 2024

The incorporation of palliative care specific to mental health services and therapy remains underutilized in the care of patients with pancreatic cancer.

Managing Pancreatic Cancer Through Risk Factors, Diagnosis, and AEs
Managing Pancreatic Cancer Through Risk Factors, Diagnosis, and AEs

November 18th 2024

The 18-month overall survival rate with the mitazalimab combination in OPTIMIZE-1 exceeds a historical rate achieved with FOLFIRINOX alone.
Mitazalimab Combo Yields Meaningful Survival Benefit in Metastatic PDAC

November 7th 2024

The updated Prescription Drug User Fee Act date for zenocutuzumab in these indications is February 4, 2025.
FDA Extends Review Period for Zenocutuzumab in NRG1+ PDAC, NSCLC

November 5th 2024

Study data show that no patient with a response required opioids after a 24-hour post-procedure follow-up.
Transvascular Approach May Reduce Pain, Improve QOL in Pancreatic Cancer

November 2nd 2024